✦ LIBER ✦

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

✍ Scribed by G. Philip; K. Malmstrom; F. C. Hampel Jr; S. F. Weinstein; C. F. LaForce; P. H. Ratner; M.-P. Malice; T. F. Reiss; for the Montelukast Spring Rhinitis Study Group

Book ID: 108688587
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 31 KB
Volume: 39
Category: Article
ISSN: 0954-7894
DOI: 10.1111/j.1365-2222.2009.03360.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting adenosine receptors in the tre

Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study

✍ J. Rimmer; H. L. Peake; C. M.C. Santos; M. Lean; P. Bardin; R. Robson; B. Hauman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 760 KB

Randomized placebo-controlled trial comp

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis

✍ G. Di Lorenzo; M. L. Pacor; M. E. Pellitteri; G. Morici; A. Di Gregoli; C. Lo Bi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Randomized placebo-controlled trial comp

✍ G. Di Lorenzo; M. L. Pacor; M. E. Pellitteri; G. Morici; A. Di Gregoli; C. Lo Bi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to

Efficacy and safety of bilastine 20 mg c

Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study

✍ P. Kuna; C. Bachert; Z. Nowacki; P. Van Cauwenberge; I. Agache; L. Fouquert; A. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

Aspirin for primary thrombosis preventio

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody–positive individuals

✍ Doruk Erkan; Melanie J. Harrison; Roger Levy; Margaret Peterson; Michelle Petri; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Objective To determine the efficacy of a daily dose of 81 mg aspirin in primary thrombosis prevention in asymptomatic, persistently antiphospholipid antibody (aPL)–positive individuals (those with positive aPL but no vascular and/or pregnancy events). ## Methods The Antiphospholip